These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8722499)

  • 41. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
    Hervás I; Artigas F
    Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity.
    Pellegrino TC; Bayer BM
    Brain Behav Immun; 2002 Apr; 16(2):87-103. PubMed ID: 11908920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE; Boikess S; Luo B; Dawson LA
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA; Li P
    J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subchronic fluoxetine administration to rats: effects on 5-HT autoreceptor activity as measured by in vivo microdialysis.
    Dremencov E; Gur E; Lerer B; Newman ME
    Eur Neuropsychopharmacol; 2000 Jul; 10(4):229-36. PubMed ID: 10871704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC; Sanger DJ
    Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release.
    Pellegrino TC; Bayer BM
    Neuroimmunomodulation; 2000; 8(4):179-87. PubMed ID: 11251392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
    Yoo SB; Kim BT; Kim JY; Ryu V; Kang DW; Lee JH; Jahng JW
    Psychoneuroendocrinology; 2013 Jun; 38(6):777-88. PubMed ID: 23010142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography.
    Pejchal T; Foley MA; Kosofsky BE; Waeber C
    Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A; Rivet JM; Cistarelli L; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes.
    García-Pedraza JÁ; Fernández-González JF; López C; Martín ML; Alarcón-Torrecillas C; Rodríguez-Barbero A; Morán A; García-Domingo M
    Life Sci; 2022 Mar; 293():120335. PubMed ID: 35051421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors.
    Millan MJ; Perrin-Monneyron S
    Eur J Pharmacol; 1997 Mar; 321(3):R11-3. PubMed ID: 9085055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
    Raap DK; Garcia F; Muma NA; Wolf WA; Battaglia G; van de Kar LD
    J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.
    Gur E; Dremencov E; Lerer B; Newman ME
    Eur J Pharmacol; 2001 Jan; 411(1-2):115-122. PubMed ID: 11137865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
    Gur E; Dremencov E; Van De Kar LD; Lerer B; Newman ME
    Eur J Pharmacol; 2002 Feb; 436(1-2):57-65. PubMed ID: 11834247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the in-vivo modulation of neostriatal dopamine release by fluoxetine and 5-hydroxy-L-tryptophan in conscious rats.
    Li XM; Perry KW; Fuller RW
    J Pharm Pharmacol; 1996 Aug; 48(8):825-8. PubMed ID: 8887733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression.
    Gartside SE; Leitch MM; Young AH
    Neuropsychopharmacology; 2003 Sep; 28(9):1572-8. PubMed ID: 12784107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.